Live Quiz Arena
🎁 1 Free Round Daily
⚡ Enter ArenaQuestion
← Human Body & HealthIf a patient has a genetic defect causing decreased fibrinogen production, why does platelet aggregation become impaired?
A)Reduced calcium signaling occurs
B)Thromboxane A2 production increases excessively
C)Fibrin bridges cannot form properly✓
D)Von Willebrand factor is degraded rapidly
💡 Explanation
Platelet aggregation depends on fibrinogen binding to platelet receptors to form fibrin bridges between platelets. Reduced fibrinogen impairs this mechanism, because platelets cannot effectively cross-link to create a stable plug. Therefore, aggregation is impaired, rather than proceeding normally or being related to calcium or vWF.
🏆 Up to £1,000 monthly prize pool
Ready for the live challenge? Join the next global round now.
*Terms apply. Skill-based competition.
Related Questions
Browse Human Body & Health →- Why does peripheral tissue hypothyroidism persist despite normal TSH levels and thyroid hormone production following an autoimmune attack on deiodinase enzymes?
- Which failure mode becomes likely in asthma patients who overuse beta-agonist inhalers alongside environmental histamine exposure?
- If a researcher isolates skeletal muscle fibers and introduces a non-hydrolyzable ATP analog during a contraction experiment, which consequence follows?
- A weightlifter attempts a maximum bench press. If muscle fiber recruitment plateaus while the load continues to increase, which consequence follows regarding sarcomere contraction?
- Why does anaphylaxis typically worsen with repeated exposure to the same allergen, rather than remaining constant?
- If a patient's thyroid gland is exposed to radioactive iodine, which consequence follows regarding thyroid hormone production?
